Saturday, October 21, 2017 2:11:17 AM
The Committee agreed that the condition, ovarian cancer, is a distinct medical entity and meets the criteria for orphan designation.
The intention to treat the condition with the medicinal product containing ofranergene obadenovec was considered justified based on preliminary clinical data demonstrating that treatment improved survival in recurrent platinum-resistant patients.
The condition is chronically debilitating in particular due to pain, weight loss, ascites and vaginal bleeding, and life-threatening with approximately half of the patients surviving less
than five years.The condition was estimated to be affecting approximately 3 in 10,000 persons in the
European Union, at the time the application was made.
In addition, although satisfactory methods of treatment of the condition exist in the European Union, the sponsor has provided sufficient justification for the assumption that the medicinal product containing ofranergene obadenovec will be of significant benefit to those
affected by the condition. The sponsor has provided preliminary clinical data that demonstrate that treatment improved survival in recurrent platinum-resistant patients. An indirect comparison was conducted to show that the survival benefit compared favourably
with the survival observed with authorised products. The Committee considered that this constitutes a clinically relevant advantage.
A positive opinion for ofranergene obadenovec, for treatment of ovarian cancer, was adopted by consensus'
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM